GgoogleIT HealthMedicine first seen 4 d ago, last 4 d ago, peak #1

Penn Engineers Use AI to Flag Side Effects of Unapproved GLP-1 Drug

Original: retatrutide

Researchers at the University of Pennsylvania have used artificial intelligence and data from online forums to identify potential side effects of retatrutide, an unapproved GLP-1 weight-loss drug still in development. The study highlights a new way to detect adverse reactions before regulators or manufacturers can, drawing attention as interest in next-generation obesity medications keeps growing.

Why now: Retatrutide is a closely watched experimental obesity drug, and any new research on its side effects draws wide attention.

University of PennsylvaniaretatrutideEli Lilly

Open on google →

Evidence

• What is retatrutide? Everything to know about 'RETA,' the triple-agonist weight-loss drug headed for FDA review · Clarin.com
• Penn Engineers Use AI, Reddit to Identify Potential Side Effects of Unapproved New GLP-1 · University of Pennsylvania

Elsewhere

• GgoogleNL #8 · 1 d ago
• GgoogleAU #10 · 6 d ago
• GgoogleGB #6 · 6 d ago
• GgoogleUS #4 · 6 d ago
• GgoogleBR #7 · 20 d ago

API: https://socialmediatrends-api.osmike.com/v1/trends/2375481